Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 16.06
Day High 17.04
Open:16.45
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

FEATURE-EMPTY
Description
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
- BusinessWire - Thu Sep 12, 5:31AM CDT
BusinessWire - CMTX
Thu Sep 12, 5:31AM CDT
--Antibody level predicted to protect against chikungunya infection achieved within hours; projected to be maintained for at least 16 weeks at the middle and high doses
Moderna Announces Positive Interim Results from Phase 1 Cytomegalovirus (CMV) Vaccine (mRNA-1647) Study and Progress Toward Phase 2 and Pivotal Trials
- BusinessWire - Thu Sep 12, 5:30AM CDT
BusinessWire - CMTX
Thu Sep 12, 5:30AM CDT
--Vaccine was generally well-tolerated
Moderna Appoints Tracey Franklin as Chief Human Resources Officer
- BusinessWire - Wed Sep 4, 7:00AM CDT
BusinessWire - CMTX
Wed Sep 4, 7:00AM CDT
Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Tracey Franklin has been appointed Chief Human Resources Officer. She will serve on Moderna's Executive Committee, reporting to Chief Executive Officer Stephane Bancel.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 12.47 +34.00% increase
on 08/15/19
Period Open:13.30
Price movement based on the high, low and last over the given period.
18.46 -9.48% decrease
on 09/12/19
+3.41 (+25.64%) increase
since 08/13/19
3-Month 11.54 +44.80% increase
on 08/07/19
Period Open:16.16
Price movement based on the high, low and last over the given period.
18.46 -9.48% decrease
on 09/12/19
+0.55 (+3.40%) increase
since 06/13/19
52-Week 11.54 +44.80% increase
on 08/07/19
Period Open:18.60
Price movement based on the high, low and last over the given period.
29.79 -43.91% decrease
on 04/08/19
-1.89 (-10.16%) decrease
since 12/07/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).